FDA Authorizes Pfizer Covid-19 Vaccine for Children 5-11
By Radiant HealthPublished: October 31, 2021

The FDA has authorized Pfizer’s COVID-19 vaccine for children ages 5 to 11. The children’s dose is one-third (10mcg) of that given to teens and adults and would be administered in two doses, three weeks apart. Vaccination for this age group is anticipated to begin as early as next week. Moderna said last week that a low dose of its vaccine is effective in children 6-11 and could be available in a few weeks. However, the company is yet to submit its data to the FDA for review.
Like what you're reading? Sign up for our free newsletter and never miss a post! Plus get a FREE digital version of our Issue No.10 with sign up.

- Pfizer’s Antiviral Pill is Very Effective - May 15, 2022
- Spain Considers Three Days Off for Menstrual Pain - May 15, 2022
- Moderna Requests Approval for its Children’s Vaccine - May 15, 2022
- Routine Colonoscopies Should Start at Age 45 - May 15, 2022
- Anti-inflammatory Drugs May Do More Harm Than Good - May 15, 2022
- Some People Die from a Happy Heart - May 8, 2022
- Johnson & Johnson Vaccine Can Cause Serious Blood Clots - May 8, 2022
- Omicron Variants Spreading Quickly - May 8, 2022
- Roe V. Wade Will Likely Be Overturned - May 8, 2022
- Menthol Cigarette Ban Will Benefit the Black Community - April 30, 2022